Hot Pursuit     02-Jan-24
Zydus Lifesciences Ltd gains for third straight session
Zydus Lifesciences Ltd is quoting at Rs 711, up 1.69% on the day as on 12:49 IST on the NSE. The stock is up 67.43% in last one year as compared to a 18.64% jump in NIFTY and a 36.1% jump in the Nifty Pharma index.

Zydus Lifesciences Ltd is up for a third straight session today. The stock is quoting at Rs 711, up 1.69% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.51% on the day, quoting at 21632. The Sensex is at 71811.63, down 0.64%. Zydus Lifesciences Ltd has gained around 12.25% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 6.02% in last one month and is currently quoting at 16858.75, up 2.06% on the day. The volume in the stock stood at 17.57 lakh shares today, compared to the daily average of 18.49 lakh shares in last one month.

The benchmark January futures contract for the stock is quoting at Rs 715, up 1.44% on the day. Zydus Lifesciences Ltd is up 67.43% in last one year as compared to a 18.64% jump in NIFTY and a 36.1% jump in the Nifty Pharma index.

The PE of the stock is 28.35 based on TTM earnings ending September 23.

Previous News
  Sensex gains 239 pts; metal shares shine; VIX rallies 3.35%
 ( Market Commentary - Mid-Session 31-Jul-24   12:33 )
  Zydus enters into non-exclusive patent licensing agreement with Takeda
 ( Corporate News - 17-Jul-24   15:41 )
  Zydus' transdermal patch manufacturing facility completes USFDA inspection
 ( Corporate News - 01-Oct-24   12:26 )
  Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr
 ( Hot Pursuit - 09-Aug-24   15:38 )
  Zydus receives Mexican regulatory approval for breast cancer drug
 ( Corporate News - 31-Jul-24   14:00 )
  Zydus Life rises on USFDA nod for dyskinesia treatment drug
 ( Hot Pursuit - 28-Aug-24   09:57 )
  Zydus Lifes rises after receiving approval from COFEPRIS for Trastuzumab biosimilar
 ( Hot Pursuit - 31-Jul-24   12:09 )
  Zydus receives USFDA tentative approval for Azilsartan Medoxomil and Chlorthalidone Tablets
 ( Corporate News - 14-Jun-24   13:42 )
  Zydus Lifesciences Ltd spurts 7.01%, up for third straight session
 ( Hot Pursuit - 12-Feb-24   13:05 )
  Zydus Lifesciences consolidated net profit rises 109.70% in the June 2023 quarter
 ( Results - Announcements 11-Aug-23   17:49 )
  Zydus Life’s Ahmedabad facility gets EIR from USFDA
 ( Hot Pursuit - 01-Oct-24   12:13 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top